SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Trans Lux Corp. 
 NY
  SEC # 99106


        
    Click to view...      Registrant      About      Filings      Files      Relationships      Names    
  Topics  
    Web       

165  Topics
Topic emoji
 within the 

Show:   Most-Recent Document   All Documents   And:   Exhibits  

 As Of  Filing  Doc.  Page    Title Docs.
  In ascending order
5/3/23DEF 14A1Audit Committee Report
4/1/24New Filing!  10-K1Business
1Certain Relationships and Related Transactions, and Director Independence
1Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
8/11/2310-Q1Condensed Consolidated Balance Sheets -- June 30, 2023 and December 31, 2022 (see Note 1)
5/15/2310-Q1Condensed Consolidated Balance Sheets -- March 31, 2023 and December 31, 2022 (see Note 1)
11/9/2310-Q1Condensed Consolidated Balance Sheets -- September 30, 2023 and December 31, 2022 (see Note 1)
1Condensed Consolidated Statements of Cash Flows -- Nine Months Ended September 30, 2023 and 2022
8/11/2310-Q1Condensed Consolidated Statements of Cash Flows -- Six Months Ended June 30, 2023 and 2022
5/15/2310-Q1Condensed Consolidated Statements of Cash Flows -- Three Months Ended March 31, 2023 and 2022
11/9/2310-Q1Condensed Consolidated Statements of Changes in Stockholders' Deficit -- Three and Nine Months Ended September 30, 2023 and 2022
8/11/2310-Q1Condensed Consolidated Statements of Changes in Stockholders' Deficit -- Three and Six Months Ended June 30, 2023 and 2022
5/15/2310-Q1Condensed Consolidated Statements of Changes in Stockholders' Deficit -- Three Months Ended March 31, 2023 and 2022
11/9/2310-Q1Condensed Consolidated Statements of Comprehensive Loss (Income) -- Three and Nine Months Ended September 30, 2023 and 2022
8/11/2310-Q1Condensed Consolidated Statements of Comprehensive Loss -- Three and Six Months Ended June 30, 2023 and 2022
5/15/2310-Q1Condensed Consolidated Statements of Comprehensive Loss -- Three Months Ended March 31, 2023 and 2022
11/9/2310-Q1Condensed Consolidated Statements of Operations -- Three and Nine Months Ended September 30, 2023 and 2022
8/11/2310-Q1Condensed Consolidated Statements of Operations -- Three and Six Months Ended June 30, 2023 and 2022
5/15/2310-Q1Condensed Consolidated Statements of Operations -- Three Months Ended March 31, 2023 and 2022
4/1/24New Filing!  10-K1Consolidated Balance Sheets as of December 31, 2023 and 2022
1Consolidated Statements of Changes in Stockholders' Deficit for the Years Ended December 31, 2023 and 2022
1Consolidated Statements of Comprehensive Loss for the Years Ended December 31, 2023 and 2022
1Consolidated Statements of Operations for the Years Ended December 31, 2023 and 2022
1Controls and Procedures
5/3/23DEF 14A1Corporate Governance and Related Matters
4/1/24New Filing!  10-K1Cybersecurity
11/9/2310-Q1Defaults upon Senior Securities
5/3/23DEF 14A1Delinquent Section 16(A) Reports
4/1/24New Filing!  10-K1Directors, Executive Officers and Corporate Governance
1Disclosure Regarding Foreign Jurisdictions that Prevent Inspection
1Executive Compensation
5/3/23DEF 14A1Executive Officers
11/9/2310-Q1Exhibits
4/1/24New Filing!  10-K1Exhibits and Financial Statement Schedules
11/9/2310-Q1Financial Information (unaudited)
4/1/24New Filing!  10-K1Financial Statements and Supplementary Data
1Form 10-K Summary
5/3/23DEF 14A1General Information
4/1/24New Filing!  10-K1Item 1
1Item 10
1Item 11
1Item 12
1Item 13
1Item 14
1Item 15
1Item 16
1Item 1A
1Item 1B
1Item 1C
1Item 2
1Item 3
1Item 4
1Item 5
1Item 6
1Item 7
1Item 7A
1Item 8
1Item 9
1Item 9A
1Item 9B
1Item 9C
8/11/2310-Q1June 30, 2023 and December 31, 2022 (see Note 1)
4/1/24New Filing!  10-K1Legal Proceedings
1Management's Discussion and Analysis of Financial Condition and Results of Operations
5/15/2310-Q1March 31, 2023 and December 31, 2022 (see Note 1)
4/1/24New Filing!  10-K1Market for the Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
1Mine Safety Disclosures
11/9/2310-Q1Nine Months Ended September 30, 2023 and 2022
1Notes to Condensed Consolidated Financial Statements
4/1/24New Filing!  10-K1Notes to Consolidated Financial Statements
1Other Information
5/3/23DEF 14A1Other Matters
4/1/24New Filing!  10-K1Part I
11/9/2310-Q1Part I -- Financial Information (unaudited)
4/1/24New Filing!  10-K1Part Ii
11/9/2310-Q1Part II -- Other Information
4/1/24New Filing!  10-K1Part Iii
1Part Iv
1Principal Accounting Fees and Services
1Properties
5/3/23DEF 14A1PROPOSAL 1(a) ADVISORY RESOLUTION ON EXECUTIVE COMPENSATION
1PROPOSAL 1(b) ADVISORY VOTE ON THE FREQUENCY OF FUTURE ADVISORY VOTES ON EXECUTIVE COMPENSATION
1Proposal 2 Election of Directors
1Proposal 3 Ratification of Independent Registered Public Accounting Firm
4/1/24New Filing!  10-K1Quantitative and Qualitative Disclosures About Market Risk
1Removed and Reserved
1Report of Independent Registered Public Accounting Firm (PCAOB ID 688)
1Risk Factors
5/3/23DEF 14A1Security Ownership of Certain Beneficial Owners and Management
4/1/24New Filing!  10-K1Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
11/9/2310-Q1September 30, 2023 and December 31, 2022 (see Note 1)
4/1/24New Filing!  10-K1Signatures
8/11/2310-Q1Six Months Ended June 30, 2023 and 2022
4/1/24New Filing!  10-K1Table of Contents
11/9/2310-Q1Three and Nine Months Ended September 30, 2023 and 2022
8/11/2310-Q1Three and Six Months Ended June 30, 2023 and 2022
5/15/2310-Q1Three Months Ended March 31, 2023 and 2022
8/11/2310-Q1Unregistered Sales of Equity Securities and Use of Proceeds
11/9/2310-Q1Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities
4/1/24New Filing!  10-K1Unresolved Staff Comments
5/3/23DEF 14A1Voting Procedures
1Where You Can Find More Information

Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 1, 3:31:15.1am ET